Campath®-1H Sensitivity (CD52)

The Campath®-1H Sensitivity (CD52) test contains 1 test with 3 biomarkers.

Campath® (Alemtuzumab) is indicated for the treatment of patients with CD52 positive chronic lymphocytic leukemia.
  • No Prescription Needed
  • Discounts up to 80%
  • Hundreds of Lab Tests Available

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Campath1H Sensitivity CD52

Result:

Sample Description:

Viability:

Search by Zip Code

No Results Found

There are no results that match the search criteria submitted.
Please change the criteria and try again.